QIAGEN Welcomes 3,000th Employee in 20th year of U.S. ...(ive Committee economic slowdowns are les...)

Date:12/15/2008

ive Committee, economic slowdowns are less likely to affect molecular diagnostics, biotech industry, life science research and QIAGEN than other sectors and companies. "Public and private budgets in the healthcare industry are more robust than in other sectors. And due to QIAGEN's prominence in multiple laboratory applications in the U.S. and globally, our business is expected to continue growing," says Liu. QIAGEN technologies are used to prepare and analyze biologic samples, such as blood and tissue and are regarded as standards in academic research, pharmaceutical research, forensic labs, molecular diagnostics and other research applications. Last month, QIAGEN announced strong quarterly results, allowing the company to raise its earnings guidance for the second time this year. The U.S. significantly contributed to this development, as the fastest growing global market segment for QIAGEN, with a growth rate of almost 30 percent.

"QIAGEN is one of Montgomery County's great success stories, and its continued growth as a whole and, in particular, here at its U.S. headquarters in the county since 2002, illustrates the company's strength and position as a leading global biotech company," said Dr. Pradeep Ganguly, Director, Montgomery County Department of Economic Development. "QIAGEN is one of the largest biotechnology companies in Montgomery County and contributes significantly to the county's position as a global biotech industry leader."

Montgomery County, Maryland is home to more than 200 life sciences firms, 19 federal agencies, 30 federal labs, more than 60 international companies and more than 40,000 life science professionals working throughout the private sector, federal laboratories, foundations and academia.

According to the Maryland Department of Business and Economic Development, foreign investment in the biotech sector -- one of the fastest-growing business segments -- accounts for more t
'/>"/>

SOURCE QIAGEN Copyright©2008 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4
Related biology technology :

1. SciQuest Announces Strategic Alliance with QIAGEN
2. Webcast of QIAGEN N.V.s (Nasdaq: QGEN) Second Quarter 2008 Financial Results Call Set for August 5
3. Webcast Alert: QIAGEN N.V. Announces First Quarter 2008 Earnings Conference Call
4. QIAGEN N.V. (Nasdaq: QGEN) Invites You to Join Its Fourth Quarter and Year End 2007 Earnings and 2008 Guidance Conference Call on the Web
5. Histogen Welcomes Dr. Hyma Gollamudi as Chief Business Officer
6. Trusted LASIK Surgeons Welcomes LASIK Expert Michael Raizman of Boston to its Unique LASIK Directory
7. South Africas Minister of Minerals and Energy Welcomes Denham Capital Investment in BioTherm Energy to Develop Power Generation Business
8. Vineland Welcomes Dr. Isabelle Lesschaeve as Research Chair, Sensory and Consumer Sciences
9. Sigma-Aldrich Welcomes Memorial Sloan-Kettering Cancer Center to the RNAi Partnership Program
10. Vineland Welcomes Dr. Daryl Somers as Research Chair, Molecular Breeding and Biotechnology
11. Spring Point Project Welcomes Second Generation Medical-Grade Piglets